Jefferson Capital JCAP 深 沪
等待开盘 03-26 09:30:00 美东时间
19.47
+0.170
+0.88%
华盛通- 最 高19.62
- 今 开19.49
- 成交量 32.92万股
- 最 低 19.00
- 昨 收 19.30
- 总市值 12.00亿
- 52周最高 23.56
- 市盈率 静 3.11
- 换手率 0.53%
- 52周最低 15.26
- 委 比 25.26%
- 总股本 6162.92万
- 历史最高 23.56
- 量 比 0.40
- 振 幅 3.21%
- 历史最低 15.26
- 每 手 1
- 风险率 2.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Jefferson Capital Appoints Two New Independent Directors
MINNEAPOLIS, March 18, 2026 (GLOBE NEWSWIRE) -- Jefferson Capital, Inc. announced the appointment of Susan Atkins and James Pierce to its Board of Directors, effective March 18, 2026. Christopher Giles is stepping down from the Board to focus on other professional commitments. Susan Atkins brings over 40 years of experience in corporate finance, risk management, and governance, while James Pierce has extensive expertise in technology leadership a...
03-18 20:05
Earnings Scheduled For March 12, 2026
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
Jefferson Capital to Announce Fourth Quarter and Full Year 2025 Results
Jefferson Capital, Inc. (NASDAQ: JCAP), a leading purchaser and manager of consumer accounts, announced it will release 4Q2025 financial results on March 12, followed by a webcast at 5:00 pm ET. investors.jcap.com offers live webcast and replay access. Founded in 2002, the company operates globally, serving Fortune 500 creditors, banks, fintech platforms, and others. Contact: IR@jcap.com or Doug.Donsky@icrinc.com.
02-26 21:05
Jefferson Capital stockholders plan secondary offering; company to repurchase shares
Jefferson Capital (JCAP) said on Monday that certain existing stockholders plan to sell 10 million shares of the company’s common stock in an underwritten secondary public offering. The underwriters w...
01-06 05:22
Jefferson Capital Announces Launch of Secondary Public Offering and Concurrent Share Repurchase
Jefferson Capital, Inc. announced a secondary offering of 10 million shares, with underwriters having an option to purchase up to 1.5 million additional shares. The company plans to repurchase 3 million shares, which will be retired. The offering is supported by multiple underwriters, and a preliminary prospectus is available. The press release includes customary forward-looking disclaimers and risk factors.
01-05 21:17
Why Vanda Pharmaceuticals Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) rose sharply in pre-market a...
2025-12-31 19:14
Keefe, Bruyette & Woods Reiterates Outperform on Jefferson Capital, Maintains $28 Price Target
Keefe, Bruyette & Woods analyst Bose George reiterates Jefferson Capital (NASDAQ:JCAP) with a Outperform and maintains $28 price target.
2025-12-25 02:04
Jefferson Capital Completes Acquisition of Credit Card Portfolio
Jefferson Capital, Inc. (NASDAQ: JCAP) completed the acquisition of credit card assets from Bluestem Brands affiliates, with a net purchase price of $196.7 million and estimated collections of $311.4 million. Founded in 2002, Jefferson Capital is a global purchaser and manager of charged-off and active consumer accounts, operating across the U.S., Canada, the U.K., and Latin America. The company serves Fortune 500 creditors, banks, fintech platfo...
2025-12-04 21:10
Semtech Posts Mixed Q3 Results, Joins Zhihu, Nvidia And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling around...
2025-11-25 21:01
美股大行评级 | Stifel上调特斯拉目标价升至508美元；多家大行上调Vita Coco目标价最高至58美元
今日重点评级关注：HC Wainwright & Co.：维持Oncolytics Biotech"买入"评级，目标价从5美元升至10美元；HC Wainwright & Co.：维持Barinthus Biotherapeutics"买入"评级，目标价从3美元升至4美元
2025-11-18 15:28
